Strand Therapeutics

Strand Therapeutics

  • Founded: 2018
  • Location: Boston, MA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: Undisclosed
  • Product link:
  • Funding: $45M A Nov 2022; $52M A Jun 2021; $6M seed Jun 2019
  • Investors: FPV, Eli Lilly and Company, Potentum Partners, Playground Global

job board

Short description:

Gene Therapy

Drug notes:

Undisclosed RD hematological cancers

Long description:

Strand Therapeutics is developing mRNA therapeutics to treat cancer, heart diseases and rare diseases. mRNA has recently emerged as an effective, multi-functional and potentially curative treatment option for many patients. Strand’s approach to mRNA therapeutics is unique - creating mRNA constructs that contain information for self-replication and genetically programmed logic circuits. This application of synthetic biology to RNA therapeutics enables the creation of programmable, long-acting mRNA drugs such that the location, timing and intensity of expression can all be controlled. Stand has initially focused on treatment options for solid tumor cancers.


Strand Therapeutics
Associate Scientist, Nanoparticle Process Developm...
Boston, MA|46 days ago
Strand Therapeutics
Scientist/Sr Scientist, Analytical Development
Boston, MA|85 days ago
Strand Therapeutics
Principal Scientist, Translational Biology
Boston, MA|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy